Home
Valeant Pharmaceuticals

Valeant Pharmaceuticals Market Share Analysis for November 2025

Learn about Bausch Health, a global company whose mission is to improve people’s lives with our health care products.

Health > Health - Other

Domainvaleant.com

Year Founded1960

Employees> 10001

Annual Revenue--

Valeant Pharmaceuticals

Valeant Pharmaceuticals (including company regionals)

valeant.com

See more website traffic and engagement information

Total visits to Valeant Pharmaceuticals's top domains

Understand Valeant Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Valeant Pharmaceuticals's top domains

Analyze Valeant Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Valeant Pharmaceuticals's top domains

See how Valeant Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Valeant Pharmaceuticals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

bausch.comCompany NameBausch + LombEmployees> 10001HQUnited States, New Jersey, BridgewaterAnnual revenue> $1BTotal visits405.1KHealth > Health - Other

Top technologies used by Valeant Pharmaceuticals

These are the website technologies, by industry, used by Valeant Pharmaceuticals top domains

Payment & Currencies (24)

PayPal

eCommerce (3)

USPS

Advertising (2)

DoubleClick

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from Valeant Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsValeant Pharmaceuticals has issues with accounting and pricing practices.Before Bausch + Lomb, he was brought in as the CEO of Bausch (BHC.TO) in 2016 as the company, formerly called Valeant, sought to get past a flurry of investigations into its accounting and pricing practices under the previous management.

NewsValeant Pharmaceuticals acquires AddyiTM for $1B.The day after the FDA approval, Valeant acquired Addyi for $1 billion.

NewsValeant Pharmaceuticals acquired Allergan PLC for $37M on Jan 1st '14.Valeant begin an endeavor to buy Allergan in 2012, but could not afford the $37 million cost, so it reached a deal with a hedge fund company called Pershing.